SEC
SlamSEC
Search
Browse
Earnings
Estrella Immunopharma, Inc.
Nasdaq:
ESLA
Nasdaq:
ESLAW
Biological Products, (No Diagnostic Substances)
·
EMERYVILLE, CA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Credit & Agreements
material agreements · debt obligations
Credit & Agreements
(8-K)
28 shown
Filed
Description
1/6/26
1.01
Material Agreement
→
6/3/25
1.01
Material Agreement
→
12/6/24
1.01
Material Agreement
→
11/7/24
1.01
AMENDMENT TO FORM 8-K
→
5/13/24
1.01
Material Agreement
→
3/7/24
1.01
Material Agreement
→
↓ 22 more
CEO
Liu Cheng
CFO
Xu Jiandong